Federal Grants Expert to Review Significant Changes in OMB?s 2015 Compliance Supplement

July 2, 2015 by  
Filed under Allergy Tips

Hello, this is your first time visiting our site!

Please enjoy, and signup for our discount coupon notification!

;

This year?s changes to the Office of Management and Budget?s (OMB) Single Audit Compliance Supplement, which captures what grantees will be tested on, are expected to be significant, stemming from the transition to new administrative requirements and cost principles, and OMB?s objective to concentrate audit resources on higher dollar and higher risk programs. Participants of the July 9 Federal Fund Management Advisor webinar, ?OMB?s 2015 Compliance Supplement for Single Audits: How to Use It for Audit Readiness,? will hear advice from federal grants expert Bob Lloyd on how the Supplement can help them be prepared for an audit.

;

Mr. Lloyd will provide 60 minutes of presentations followed by 30 minutes dedicated to individual questions. Participants will learn: ;

; Which key compliance tests have been retained (and which eliminated) and in what ways ; Where and how key text changes have been made to the cross-cutting requirements in Part 3 of the Supplement ; What adjustments have been made in the listings for specific programs and clusters of programs ; How auditors have been instructed to use the Supplement?s guidance on review of internal controls going forward ; What special advisories and alerts are being published for 2015

Visit http://federalfundmanagement.com/webinars/wg515_070915 for more details and registration information.

;

Bob Lloyd is a respected authority on policies and practices affecting the award, administration and oversight of federal grants, contracts and subawards. Mr. Lloyd has more than 40 years of experience in federal award implementation. Prior to starting his management consulting practice in Washington, D.C., in 1982, he served as the executive director of the Grants Management Advisory Service and held staff positions in two large federally funded organizations. Since then, he has been a consultant, trainer or advisor to award and audit units in 16 federal award-making departments and agencies, and to recipient and subrecipient organizations and their professional advisors located in all 50 states, the District of Columbia, several U.S. territories and 18 foreign countries. He is the principal author of several reference works on federal grants management and audits, and currently serves as contributing editor to Federal Grants News, published by Atlantic Information Services. He also is a Charter Life Member of the National Grants Management Association and served on its Board of Directors for five years.

;

Attendees of the Live Webinar Can Earn Up to 1.5 CPE Credits ;
Federal Fund Management Advisor is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: http://www.learningmarket.org.

;

About Federal Fund Management Advisor ;
Federal Fund Management Advisor provides recipients and subrecipients of federal funds with accurate, responsible and practical advice concerning the acquisition, administration and oversight of federal grants, cooperative agreements and contracts. Through management, compliance and best practices webinars, and a wide variety of technical assistance capabilities, this advisory service can help organizations navigate effectively in today?s highly charged federal fund accountability atmosphere. Visit http://www.federalfundmanagement.com.

; ; ; ; ;

    Find More Supplements Press Releases

    OrganicIndiaUSA.com

    Product Review: Herbal Cleanse Dry Shampoo on Locs

    March 21, 2015 by  
    Filed under Videos

    VIDEO

    default Product Review: Herbal Cleanse Dry Shampoo on Locs

    Watch Video Here

    Organic India

    Hair La Vie Hair Growth Vitamins Review – So It Begins

    March 18, 2015 by  
    Filed under Videos

    VIDEO

    default Hair La Vie Hair Growth Vitamins Review   So It Begins

    Products in the package: 3 months supply of Hair La Vie Check out their website at http://ow.ly/Gmosu Pure Moroccan Oil A cute T-shirt Measuring Tape Hair Growth Chart Follow Me: www.AuNaturalLo. Watch Video Here

    Organic Shatavri Formula - Feminine Harmony

    Blessed Herbs Internal Cleanse Kit Review: Part 1 (ParaCleanse)

    February 23, 2015 by  
    Filed under Videos

    VIDEO

    default Blessed Herbs Internal Cleanse Kit Review: Part 1 (ParaCleanse)

    I like this cleanse a lot. It's much easier now that I can eat "normal" meals rather than fasting on apple juice only, which is what was needed during the co... Watch Video Here

    Organic Triphala Formula

    Sensory Neuropathy Therapeutics Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com

    February 15, 2015 by  
    Filed under Allergy Tips

    Dallas, TX (PRWEB) February 10, 2015

    The report ?Peripheral Neuropathy (Sensory Neuropathy) ? Pipeline Review, H1 2015? provides comprehensive information on the therapeutic development for Peripheral Neuropathy (Sensory Neuropathy). Peripheral Neuropathy (Sensory Neuropathy) is a damage to one or more of peripheral nerves that includes motor, sensory and autonomic fibers. The cause of peripheral neuropathy is often unidentified. The most widespread causes of peripheral neuropathy are diabetes, shingles, kidney failure, various drugs and vitamin shortage. When the peripheral sensory nerves are damaged, they fail to send sensory messages (pain, heat, touch, cold etc). Neuropathy occurs in 60% to 70% of people with diabetes. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report is available @ http://www.rnrmarketresearch.com/peripheral-neuropathy-sensory-neuropathy-pipeline-review-h1-2015-market-report.html .

    ;

    The report also reviews key players involved in the therapeutic development for Peripheral Neuropathy (Sensory Neuropathy) and special features on late-stage and discontinued projects. Companies discussed in this Peripheral Neuropathy (Sensory Neuropathy) ? Pipeline Review, H1 2015 report include Acorda Therapeutics, Inc., aTyr Pharma, Inc., GeNeuro SA, INSYS Therapeutics, Inc., Mitsubishi Tanabe Pharma Corporation, Neuren Pharmaceuticals Limited, Pfizer Inc., RegeneRx Biopharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited.

    ;

    Symptoms of peripheral neuropathy (sensory neuropathy) includes burning pain, excessive sensitivity to touch, loss of balance and coordination, regular numbness and tingling in the hands or feet and impaired capability to sense the location of one?s limbs. Drug profiles discussed in this report includes cannabidiol, fingolimod hydrochloride, GL-2045, immune globulin, immune globulin (human), Monoclonal Antibody for CIDP, NNZ-2591, NP-1998, NRP-2945, Peptide to Activate GLP1R for CNS, Metabolic Disorders and Head Trauma, Peptides for Neuropathic Pain and Peripheral Neuropathy, Peptides to Activate GLP-1 Receptor for CNS Disorders and Head Trauma, Proteins for Inflammation, Hematological, Metabolic, Oncology, Neurodegenerative and Cardiovascular Disorder, RGN-352, Small Molecules for Peripheral Neuropathy and Amyotrophic Lateral Sclerosis, Small Molecules to Inhibit Cysteine Protease and Caspases for Oncology, Immunology, Infectious and CNS Disorders, Synthetic Peptides for Peripheral Neuropathy. Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=269576 . (This is a premium report priced at US$ 2000 for a single user License.)

    ;

    Featured News & Press Releases cover by this ?Peripheral Neuropathy (Sensory Neuropathy) ? Pipeline Review, H1 2015? report include: Jul 12, 2013: Neuren Receives Notice of Allowance for New Patent.

    ;

    Table of content

    ;

    List of Tables ;
    Number of Products under Development for Peripheral Neuropathy (Sensory Neuropathy), H1 2015 ;
    Number of Products under Development for Peripheral Neuropathy (Sensory Neuropathy) - Comparative Analysis, H1 2015 ;
    Number of Products under Development by Companies, H1 2015 ;
    Number of Products under Investigation by Universities/Institutes, H1 2015 ;
    Comparative Analysis by Late Stage Development, H1 2015 ;
    Comparative Analysis by Clinical Stage Development, H1 2015 ;
    Comparative Analysis by Early Stage Development, H1 2015 ;
    Products under Development by Companies, H1 2015 ;
    Products under Investigation by Universities/Institutes, H1 2015 ;
    Peripheral Neuropathy (Sensory Neuropathy) - Pipeline by Acorda Therapeutics, Inc., H1 2015 ;
    Peripheral Neuropathy (Sensory Neuropathy) - Pipeline by aTyr Pharma, Inc., H1 2015 ;
    Peripheral Neuropathy (Sensory Neuropathy) - Pipeline by GeNeuro SA, H1 2015 ;
    Peripheral Neuropathy (Sensory Neuropathy) - Pipeline by INSYS Therapeutics, Inc., H1 2015 ;
    Peripheral Neuropathy (Sensory Neuropathy) - Pipeline by Mitsubishi Tanabe Pharma Corporation, H1 2015 ;
    Peripheral Neuropathy (Sensory Neuropathy) - Pipeline by Neuren Pharmaceuticals Limited, H1 2015 24 ;
    Peripheral Neuropathy (Sensory Neuropathy) - Pipeline by Pfizer Inc., H1 2015 ;
    Peripheral Neuropathy (Sensory Neuropathy) - Pipeline by RegeneRx Biopharmaceuticals, Inc., H1 2015 ;
    Peripheral Neuropathy (Sensory Neuropathy) - Pipeline by Takeda Pharmaceutical Company Limited, H1 2015 ;
    Peripheral Neuropathy (Sensory Neuropathy) - Pipeline by Teijin Pharma Limited, H1 2015 ;
    Assessment by Monotherapy Products, H1 2015 ;
    Number of Products by Stage and Target, H1 2015 ;
    Number of Products by Stage and Mechanism of Action, H1 2015 ;
    Number of Products by Stage and Route of Administration, H1 2015 ;
    Number of Products by Stage and Molecule Type, H1 2015 ;
    Peripheral Neuropathy (Sensory Neuropathy) Therapeutics - Recent Pipeline Updates, H1 2015 ;
    Peripheral Neuropathy (Sensory Neuropathy) - Dormant Projects, H1 2015 ;
    Peripheral Neuropathy (Sensory Neuropathy) - Discontinued Products, H1 2015

    ;

    Explore more reports on Central Nervous System (CNS) therapeutics Market at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/central-nervous-system-cns-therapeutics .

    ;

    About Us: ;
    RnRMarketResearch.com is a database of selected syndicated market reports for global and China industries including but not limited to life sciences, information technology & telecommunications, consumer goods, food and beverages, energy and power, automotive and transportation, manufacturing and construction, materials and chemicals, public sector as well as business and financial services. We provide 24/7 online and offline support to our customers.

    ; ; ; ; ;

      Related Vitamins Press Releases

      Organic Neem Formula

      Follicular Thyroid Cancer Therapeutics Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com

      February 15, 2015 by  
      Filed under Allergy Tips

      Dallas, TX (PRWEB) February 10, 2015

      The report ?Follicular Thyroid Cancer ? Pipeline Review, H1 2015? provides comprehensive information on the therapeutic development for Follicular Thyroid Cancer. Peripheral Neuropathy (Sensory Neuropathy) is a damage to one or more of peripheral nerves that includes motor, sensory and autonomic fibers. The cause of peripheral neuropathy is often unidentified. The most widespread causes of peripheral neuropathy are diabetes, shingles, kidney failure, various drugs and vitamin shortage. When the peripheral sensory nerves are damaged, they fail to send sensory messages (pain, heat, touch, cold etc). Neuropathy occurs in 60% to 70% of people with diabetes. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report is available at http://www.rnrmarketresearch.com/follicular-thyroid-cancer-pipeline-review-h1-2015-market-report.html.

      ;

      The report also reviews key players involved in the therapeutic development for Follicular Thyroid Cancer and special features on late-stage and discontinued projects. Companies discussed in this Follicular Thyroid Cancer ? Pipeline Review, H1 2015 report include AstraZeneca PLC, Exelixis, Inc., GlaxoSmithKline plc, Novartis AG, Pfizer Inc.

      ;

      The most universal signs and symptoms of thyroid cancer includes a lump, thyroid nodule, trouble swallowing, throat or neck pain, swollen lymph nodes in the neck, cough and vocal changes. It is not possible to prevent most cases of thyroid cancer. Drug profiles discussed in this report includes cabozantinib s-malate, dabrafenib mesylate, everolimus, sunitinib malate, tetraiodothyroacetic acid nanoparticle, vandetanib. Order a Purchase copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=269533. (This is a premium report priced at US$ 2000 for a single user License.)

      ;

      Featured News & Press Releases cover by this ?Follicular Thyroid Cancer ? Pipeline Review, H1 2015? report include: Oct 31, 2005: FDA Grants ZD6474 (Zactima) Orphan Drug Designation For The Investigation Of Rare Forms Of Thyroid Cancer

      ;

      Table of contents

      ;

      List of Tables ;
      Number of Products under Development for Follicular Thyroid Cancer, H1 2015 ;
      Number of Products under Development for Follicular Thyroid Cancer - Comparative Analysis, H1 2015 ;
      Number of Products under Development by Companies, H1 2015 ;
      Number of Products under Investigation by Universities/Institutes, H1 2015 ;
      Comparative Analysis by Late Stage Development, H1 2015 ;
      Comparative Analysis by Clinical Stage Development, H1 2015 ;
      Comparative Analysis by Early Stage Development, H1 2015 ;
      Products under Development by Companies, H1 2015 ;
      Products under Investigation by Universities/Institutes, H1 2015 ;
      Follicular Thyroid Cancer - Pipeline by AstraZeneca PLC, H1 2015 ;
      Follicular Thyroid Cancer - Pipeline by Exelixis, Inc., H1 2015 ;
      Follicular Thyroid Cancer - Pipeline by GlaxoSmithKline plc, H1 2015 ;
      Follicular Thyroid Cancer - Pipeline by Novartis AG, H1 2015 ;
      Follicular Thyroid Cancer - Pipeline by Pfizer Inc., H1 2015 ;
      Assessment by Monotherapy Products, H1 2015 ;
      Number of Products by Stage and Target, H1 2015 ;
      Number of Products by Stage and Mechanism of Action, H1 2015 ;
      Number of Products by Stage and Route of Administration, H1 2015 ;
      Number of Products by Stage and Molecule Type, H1 2015 ;
      Follicular Thyroid Cancer Therapeutics - Recent Pipeline Updates, H1 2015 ;
      Follicular Thyroid Cancer - Dormant Projects, H1 2015

      ;

      List of Figures ;
      Number of Products under Development for Follicular Thyroid Cancer, H1 2015 ;
      Number of Products under Development for Follicular Thyroid Cancer - Comparative Analysis, H1 2015 ;
      Number of Products under Development by Companies, H1 2015 ;
      Assessment by Monotherapy Products, H1 2015 ;
      Number of Products by Top 10 Targets, H1 2015 ;
      Number of Products by Stage and Top 10 Targets, H1 2015 ;
      Number of Products by Top 10 Mechanism of Actions, H1 2015 ;
      Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 ;
      Number of Products by Stage and Top 10 Routes of Administration, H1 2015 ;
      Number of Products by Stage and Top 10 Molecule Types, H1 2015

      ;

      Explore more reports on Central Nervous System (CNS) therapeutics Market at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/central-nervous-system-cns-therapeutics.

      ;

      About Us: ;
      RnRMarketResearch.com is a database of selected syndicated market reports for global and China industries including but not limited to life sciences, information technology & telecommunications, consumer goods, food and beverages, energy and power, automotive and transportation, manufacturing and construction, materials and chemicals, public sector as well as business and financial services. We provide 24/7 online and offline support to our customers.

      ; ; ; ; ;

        Organic Neem Formula

        doeLEGAL Earns Recognition As One of 2014?s Top 20 Most Promising Legal Technology Providers by CIO Review Magazine

        February 12, 2015 by  
        Filed under Allergy Tips

        Wilmington, Delaware (PRWEB) February 12, 2015

        doeLEGAL, innovator of collaborative legal services for corporate legal departments and law firms, was listed as one of the Top 20 Most Promising Legal Technology Providers for 2014. The list is published by CIO Review Magazine and is the result of their evaluation of 200 nominated companies' legal services, technologies, and business practices. Heralded as ?The Navigator for Enterprise Solutions,? CIO Review?s Legal Supplement is delivered to over 102,000 readers, including senior legal leaders, as a resource to gain deeper knowledge of the available solution providers. doeLEGAL is proud to be recognized in this very prestigious list of legal technology solutions providers seen as, ??ones that are at the forefront of tackling the technology challenges in the legal arena? for 2014.

        ;

        Working with some of the most notable Fortune 500 global corporations and AMLaw 100 law firms has earned doeLEGAL their world-renown reputation for innovation. Moving towards a more collaborative legal world, they develop configurable legal enterprise solutions to meet their clients growing needs. They provide the only predictable cost of ownership pricing model tied to superior software and technology, all backed by their client-focused support.

        ;

        Through a long 44-year history of providing advanced technology to the legal market, doeLEGAL remains one of the only technology providers that remains client-focused, helping deliver on their promise to earn their customers? business every day. You can read their full profile in the online Legal Supplement magazine. When you are seeking a true partner to help reach your organization?s goals, doeLEGAL is ready to answer the call.

        ;

        Request your demo today that will assist in gaining a competitive advantage in your own, unique legal world by visiting our demo page.

        ;

        About doeLEGAL: ;
        doeLEGAL remains on the leading edge of the collaborative legal innovations provided to corporations? legal departments and law firms for both eDiscovery and eBilling. doeLEGAL is dedicated to earning every client?s business every day through a new 5-tenet differentiation model including predictable cost of ownership, distinctly superior technology & software, configured to your unique world, exceptional client-focused support, with solutions built on a foundation of collaboration. As the legal needs of clients change, they continually increase their capabilities to match the new demand in both technology and personnel. doeLEGAL holds distinctive expertise in Legal Spend and Litigation Management, making them uniquely qualified to add greater value to each legal solution. For more information, please contact doeLEGAL at 302-798-7500 or e-mail info(at)doelegal(dot)com. ;

        ; ; ; ; ;

          Find More Supplements Press Releases

          Original Tulsi Tea

          Nature’s Bounty Hair Skin & Nails Vitamins Review

          February 12, 2015 by  
          Filed under Videos

          VIDEO

          default Natures Bounty Hair Skin & Nails Vitamins Review

          NEW Make up Channel https://www.youtube.com/watch?v=OBaLFtFOR5k. Grow 1 Inch of Hair in 7 Days!! -Inversion Method #1 Results https://www.youtube.com/watch?v... Watch Video Here

          The Goddess Set

          HAIR GROWTH PILLS?! Hairfinity Vitamins Review

          January 28, 2015 by  
          Filed under Videos

          VIDEO

          default HAIR GROWTH PILLS?! Hairfinity Vitamins Review

          Can a vitamin seriously make my hair grow FAST and LONG?!! Let's take the Hairfinity challenge and see if these things are actually worth the money. *OPEN ME... Watch Video Here

          Organic Turmeric Formula

          The Incredible Bulk: Review Examining Ben Pakulski?s Brand New Bulking Muscle Building Diet Program Released

          January 26, 2015 by  
          Filed under Allergy Tips

          Houston, TX (PRWEB) January 22, 2015

          The Incredible Bulk is a revolutionary method put together by IFBB Pro Bodybuilder Ben Pakulski to increase lean muscle by up to 30lbs in less than 12 weeks without traditional bulking. This has caught the attention of HealthyandFitZone.com?s Stan Stevenson, prompting an investigative review.

          ;

          ?Our Incredible Bulk review shows that it is a step-by-step, scientific diet formula that allows the body to pack on a massive amount of lean muscle. But in addition to this, it doesn?t allow the traditional anabolic slowdown and therefore fat increase that we all fight so hard against,? reports Stevenson. ?The program is literally provided to you step by step. There?s no doubting what you need to do each and every day to ensure that you?re either priming or growing muscle.?

          ;

          The Incredible Bulk review shows it is all set out in five great sections: The Incredible Bulk Diet, The Incredible Bulk Supplement Stacks, The Incredible Bulk Workout Guide for Pure Muscle, The Incredible Bulk Web App and Ben?s Personal Grocery Shopping List for Massive Size. The program switches between two distinct phases: Cyclical Bulking RESET Phase and Cyclical Bulking GROWTH Phase. The two stages are scientifically researched and proven. Not only that, but the system tells one exactly when to switch from the Reset Phase to the Growth Phase. Absolutely nothing is left to chance with this program.

          ;

          ?This is the only dietary supplement on the market today that contains the combination of three potent, all natural compounds. This is a complete antidote to all the dieting you?ve probably done over the years,? says Stevenson. ?Following the program helps you sleep well, have more energy. You put on massive amounts of lean muscle while doing so. The science behind how it works is explained in an interesting and easy to follow way.?

          ;

          ?The Incredible Bulk really does do what it says on the tin, which is giving you a revolutionary method of bulking without the gross fat gain that everyone thinks is necessary to get bigger. In a nutshell, we have to say that we think if you give it a try, you?re going to be one happy (and ripped guy. This is a radical yet proven method of bulking without gaining fat. If you want to build muscle, get ripped and do it as fast as possible without ending up looking like a fat ass while you?re bulking, then the program has literally been created for you.?

          ;

          Those wishing to purchase The Incredible Bulk, or for more information, click here.

          ;

          To access a comprehensive Incredible Bulk review, visit http://healthyandfitzone.com/incredible-bulk-review

          ; ; ; ; ;

            Find More Supplements Press Releases

            Organic Bowel Care Formula

            Next Page »